查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
載體篩查市場規模、份額和趨勢分析報告：按類型（擴展載體篩查、靶向疾病載體篩查）、條件、技術、地區、細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1178643

載體篩查市場規模、份額和趨勢分析報告：按類型（擴展載體篩查、靶向疾病載體篩查）、條件、技術、地區、細分市場預測，2023-2030 年

Carrier Screening Market Size, Share & Trends Analysis Report By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), By Medical Condition, By Technology, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

職業篩選市場的增長和趨勢

根據Grandview Research的最新報告，到2030年，全球職業篩選市場規模預計將達到28.6億美元，2023年至2030年的複合年增長率為12.4%。載體篩選技術的不斷進步以及新興市場體外受精采用率的提高預計將在預測期內推動市場增長。攜帶者從父母那裡獲得異常基因。鐮狀細胞性貧血、囊性纖維化、泰-薩克斯病、脆性 X 綜合徵和 SMA 等疾病可以通過攜帶者篩查來識別。

進行分子測試以通過尋找 DNA 中的異常來檢測突變。使用下一代測序儀進行測試就是其中之一。攜帶者可能沒有表現出任何疾病症狀或體徵。建議孕婦進行此測試，以查看胎兒是否可能存在遺傳畸形。還鼓勵孩子的男性父母參加職業篩選測試。此類遺傳畸形的早期診斷和抑制因素有望促進市場增長。該測試使用面頰組織細胞、血液或唾液樣本。

此外，精準醫學市場正在採用載體篩選。2022 年 11 月發表在《The Medical Journal of Australia》上的一篇文章指出，基因組醫學的快速創新以及基因密碼測序技術為基因攜帶者篩查創造了有利可圖的機會。為了將人口篩查整合到精準醫學中，可以使用 RE-AIM 等框架來設計調查、評估障礙和評估結果。美國採用該策略來評估人群 DNA 篩查。

醫院和監管機構為提高職業篩選的可及性而增加的戰略舉措預計將支持市場增長。例如，2022 年 6 月，NHS 宣布將 BRCA 基因檢測擴展到猶太社區。據報導，每 40 個猶太人中就有一個是 BRCA 的攜帶者，這會增加患某些癌症的機率。同樣，2022 年 6 月，UnitedHealthcare Community 提議在美國引入德系猶太人職業篩選的覆蓋計劃。

另一方面，在新興市場，有限的公共衛生篩查實踐、生殖健康和初級保健方面缺乏基因組知識以及基因組檢測的成本預計將阻礙市場增長。在印度，攜帶者基因篩查的費用從 218 美元到 290 美元不等。考慮到該地區的平均購買力，對大多數人來說成本很高。

職業篩選市場報告亮點

按類型劃分，不斷擴大的職業篩選部分預計將在預測期內實現最快的增長率。現有參與者正在積極開發產品，以擴大篩選在精準醫學和體外受精等各個領域的應用。

根據醫療條件，囊性纖維化部分預計將在 2022 年佔據重要的市場份額並呈現顯著增長。歸因於疾病發病率和攜帶者頻率的增加。玩家的產品開發可能會支持該細分市場的增長。

從技術上看，DNA 測序領域預計將在 2023 年至 2030 年以最快的複合年增長率增長。採用 NGS 技術進行產前診斷被認為是一個主要驅動因素。

按最終用途劃分，實驗室部分預計將在 2022 年佔據大部分市場份額。這是由於發達國家擁有設備齊全的設施，而新興市場農村地區的檢測也在不斷增加。

北美以 40.19% 的總市場份額鞏固了其區域地位。這是由於該地區醫院和參考實驗室的存在以及主要企業的存在。

目錄

第一章研究方法論

  • 各國市場：基本估計
  • 全球市場：複合年增長率計算
  • 按地區計算細分市場份額
  • 調查範圍和假設
  • 數據源列表
    • 來自主要採訪的數據來源
    • 按地區劃分的首次採訪數據

第二章執行摘要

  • 市場快照

3. 職業篩選市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場驅動力分析
    • 越來越多地採用體外受精和冷凍保存
    • 篩選技術的技術進步
    • 新興市場的意識不斷增強
  • 市場約束因素分析
    • 公共衛生篩查的實施有限
  • 職業篩選 - SWOT 分析，按因素（政治與法律，經濟與技術）
  • 行業分析 - 搬運工
  • 職業篩選市場：2022 年市場狀況分析
  • COVID-19 影響分析

第四章職業篩選市場：類型估計和趨勢分析

  • 職業篩選市場：類型差異分析
  • 擴大職業篩選
    • 擴大職業篩選市場
  • 靶向疾病攜帶者篩查
    • 目標疾病攜帶者篩查市場

5 職業篩查市場：醫療條件的估計和趨勢分析

  • 職業篩選市場：醫療條件變化分析
  • 囊性纖維化
    • 囊性纖維化市場
  • 泰-薩克斯病
    • 泰薩克斯病市場
  • 戈謝病
    • 戈謝病市場
  • 鐮狀細胞性貧血症
    • 鐮狀細胞病市場
  • 脊髓性肌萎縮症
    • 脊髓性肌萎縮症市場
  • 其他
    • 其他市場

第 6 章職業篩選市場：技術估計和趨勢分析

  • 職業篩選市場：技術波動分析
  • DNA測序
    • DNA測序市場
  • 聚合□鏈反應
    • 聚合□鏈反應市場
  • 微陣列
    • 芯片市場
  • 其他
    • 其他市場

第 7 章職業篩選市場：最終用戶估計和趨勢分析

  • 職業篩選市場：最終用戶差異分析
  • 醫院
    • 醫院市場
  • 研究所
    • 實驗室市場
  • 診所和診所
    • 診所/診所市場
  • 其他
    • 其他市場

8 職業篩選市場：按地區、類型、醫療條件、技術、最終用途的估計和趨勢分析

  • 2022 年和 2030 年各地區職業篩選市場份額
  • 北美
    • SWOT分析
      • 按類型劃分的北美職業篩選市場
      • 按醫療條件劃分的北美職業篩選市場
      • 按技術劃分的北美職業篩選市場
      • 北美載體篩選市場，按最終用途分類
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的美國職業篩選市場
      • 美國職業篩選市場，按醫療條件
      • 按技術劃分的美國職業篩選市場
      • 美國運營商篩選市場，按最終用途
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的加拿大職業篩選市場
      • 按醫療條件劃分的加拿大職業篩選市場
      • 按技術劃分的加拿大職業篩選市場
      • 加拿大運營商篩選市場，按最終用途分類
  • 歐洲
    • SWOT分析
      • 按類型劃分的歐洲職業篩選市場
      • 歐洲職業篩選市場，按醫療條件
      • 歐洲職業篩選市場，按技術分類
      • 歐洲運營商篩選市場，按最終用途
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 德國職業篩選市場類型
      • 德國職業篩選市場，按醫療條件
      • 德國職業篩選市場，按技術分類
      • 德國載體篩選市場，按最終用途分類
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的英國職業篩選市場
      • 按醫療條件劃分的英國職業篩選市場
      • 按技術劃分的英國職業篩選市場
      • 英國職業篩選市場，按最終用途分類
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的法國職業篩選市場
      • 法國職業篩選市場，按醫療條件
      • 法國職業篩選市場，按技術分類
      • 法國運營商篩選市場，按最終用途分類
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的意大利職業篩選市場
      • 意大利職業篩選市場，按醫療條件
      • 意大利職業篩選市場，按技術分類
      • 意大利載體篩選市場，按最終用途分類
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 西班牙職業篩選市場按類型
      • 西班牙職業篩選市場，按醫療條件
      • 西班牙按技術劃分的職業篩選市場
      • 西班牙職業篩選市場，按最終用途分類
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的丹麥職業篩選市場
      • 按醫療條件劃分的丹麥職業篩選市場
      • 按技術劃分的丹麥職業篩選市場
      • 丹麥載體篩選市場，按最終用途分類
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的瑞典職業篩選市場
      • 按醫療條件劃分的瑞典職業篩選市場
      • 按技術劃分的瑞典職業篩選市場
      • 瑞典運營商篩選市場，按最終用途分類
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的挪威職業篩選市場
      • 按醫療條件劃分的挪威職業篩選市場
      • 按技術劃分的挪威職業篩選市場
      • 挪威職業篩選市場，按最終用途分類
  • 亞太地區
    • SWOT分析
      • 按類型分列的亞太職業篩選市場
      • 亞太地區職業篩選市場，按醫療條件
      • 按技術劃分的亞太職業篩選市場
      • 亞太地區運營商篩選市場，按最終用途
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 日本按類型劃分的職業篩選市場
      • 日本職業篩選市場，按醫療條件
      • 日本職業篩選市場，按技術分類
      • 日本載體篩選市場，按最終用途分類
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的中國職業篩選市場
      • 中國職業篩選市場，按醫療條件
      • 按技術劃分的中國職業篩選市場
      • 中國載體篩選市場，按最終用途分類
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的印度職業篩選市場
      • 印度職業篩選市場，按醫療條件
      • 印度職業篩選市場，按技術分類
      • 印度運營商篩選市場，按最終用途分類
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型分列的韓國職業篩選市場
      • 韓國職業篩選市場，按醫療條件
      • 按技術分類的韓國職業篩選市場
      • 韓國運營商篩選市場，按最終用途分類
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的澳大利亞職業篩選市場
      • 澳大利亞職業篩選市場，按醫療條件
      • 澳大利亞職業篩選市場，按技術分類
      • 澳大利亞運營商篩選市場，按最終用途
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型分列的泰國職業篩選市場
      • 泰國職業篩選市場，按醫療條件
      • 泰國職業篩選市場，按技術分類
      • 泰國載體篩選市場，按最終用途分類
  • 拉丁美洲
    • SWOT分析
      • 按類型劃分的拉丁美洲職業篩選市場
      • 拉丁美洲職業篩選市場，按醫療條件
      • 拉丁美洲職業篩選市場，按技術分類
      • 拉丁美洲運營商篩選市場，按最終用途分類
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的巴西職業篩選市場
      • 按醫療狀況分列的巴西承運人篩查市場
      • 按技術分類的巴西職業篩選市場
      • 巴西載體篩選市場，按最終用途分類
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的墨西哥職業篩選市場
      • 墨西哥職業篩選市場，按醫療條件
      • 按技術劃分的墨西哥職業篩選市場
      • 墨西哥運營商篩選市場，按最終用途分類
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的阿根廷職業篩選市場
      • 阿根廷職業篩選市場，按醫療條件
      • 按技術劃分的阿根廷職業篩選市場
      • 阿根廷職業篩選市場，按最終用途分類
  • 多邊環境協定
    • SWOT分析
      • 按類型劃分的 MEA 職業篩選市場
      • MEA 職業篩選市場，按醫療條件
      • 按技術劃分的 MEA 職業篩選市場
      • MEA 載體篩選市場，按最終用途分類
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的阿根廷職業篩選市場
      • 阿根廷職業篩選市場，按醫療條件
      • 按技術劃分的阿根廷職業篩選市場
      • 阿根廷職業篩選市場，按最終用途分類
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型分列的沙特阿拉伯職業篩選市場
      • 按醫療條件劃分的沙特阿拉伯職業篩選市場
      • 按技術分類的沙特阿拉伯職業篩選市場
      • 沙特阿拉伯職業篩選市場，按最終用途分類
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型劃分的阿拉伯聯合酋長國職業篩選市場
      • 阿聯酋職業篩選市場，按醫療條件
      • 阿聯酋職業篩選市場，按技術分類
      • 阿聯酋職業篩選市場，按最終用途分類
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 按類型分列的科威特職業篩選市場
      • 科威特職業篩選市場，按醫療條件
      • 按技術劃分的科威特職業篩選市場
      • 科威特職業篩選市場，按最終用途分類

第九章競爭格局

  • 市場進入者概覽
  • 財務績效
  • 市場進入者分類
    • 市場領導者
      • 2022 年職業篩選市場份額分析
      • 公司簡介
      • Thermo Fisher Scientific Inc.
      • Myriad Genetics, Inc.
      • Cepheid
      • Laboratory Corporation of America Holdings
      • Otogenetics
      • Illumina Inc.
      • MedGenome
      • GeneTech
      • Centogene N.V.
      • F. Hoffman-La Roche Limited
    • 戰略規劃
      • 擴張
      • 獲得
      • 合作
      • 產品/服務發布
      • 合夥
      • 其他
Product Code: GVR-4-68040-016-9

Carrier Screening Market Growth & Trends:

The global carrier screening market size is expected to reach USD 2.86 billion by 2030 and expand at a CAGR of 12.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increase in technological advancement in carrier screening along with the rising adoption of in vitro fertilization in emerging markets is expected to boost the market growth during the forecast period. The carrier receives the abnormal gene from the parents. Disorders such as sickle cell anemia, cystic fibrosis, Tay-Sachs disease, fragile X syndrome, and SMA can be identified using carrier screening.

Molecular tests are performed to detect the mutation by finding the abnormalities in the DNA. Next-generation sequencing is one of the techniques to perform tests. There is the possibility of the carrier not showing any symptoms and signs of illness. The test is recommended for pregnant women to check whether the baby will have a chance of genetic deformities. It is also advised to the male parent of the child to undergo the carrier screening test. The early-stage disease diagnosis and restraint of these genetic deformities is expected to augment the market growth. The test involves the tissue cells of the cheeks, blood, or saliva samples.

The adoption of carrier screening in the precision medicine market is also increasing. According to the article published in November 2022, by The Medical Journal of Australia, stated that the rapid innovations in genomic medicine along with sequencing technology for genetic code created a lucrative opportunity for genetic carrier screening. For incorporating population screening into precision medicine, a framework such as RE-AIM can be employed to plan research, assess barriers, and evaluates the result. This strategy was employed to assess the population DNA screening in the U.S.

The growing strategic initiatives by hospitals and regulatory bodies to increase the accessibility of carrier screening are expected to support market growth. For instance, in June 2022, NHS announced the expansion of BRCA genetic testing for the Jewish community. Since, 1 in 40 Jews is reported to be the carrier of BRCA, which increases the probability of certain cancers. Similarly, in June 2022, UnitedHealthcare Community proposed to introduce a coverage program for Ashkenazi Jewish Carrier Screening in the U.S.

On the other hand, limited implementation of public health screening, lack of genomic knowledge for reproductive health and primary care, and cost of genomic tests in the emerging market are expected to hamper the market growth. In India, the cost of carrier genetic screening ranges from USD 218 to USD 290. Considering the average purchasing power in the region, the cost is high for the majority of the population.

Carrier Screening Market Report Highlights:

  • By type, the expanded carrier screening segment is projected to establish the fastest growth rate over the forecast period. Since increasing product development by the existing players to expand the usage of screening in various fields, such as precision medicine and IVF.
  • By medical condition, the Cystic fibrosis segment is anticipated to have a significant growth rate with a considerable market share in 2022. Owing to the increase in the disease incidence rate and carrier frequency. The product development by the players is likely to support the growth of the segment.
  • By technology, the DNA sequencing segment is anticipated to have the fastest-growing CAGR between 2023 and 2030. The adoption of NGS technology for prenatal diagnostics is considered to be the key driver.
  • By end-user, the laboratory segment is projected to have a majority of the market share in 2022. This is attributed to the presence of well-equipped facilities in developed countries, along with the increasing tests in the rural areas of emerging markets.
  • North America has strengthened its regional position in the market with 40.19% of the overall market share. This is attributed to the presence of hospitals and reference labs, along with the existence of key players in the region.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Carrier Screening Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing adoption of IVF and cryopreservation
    • 3.2.2 Technology advancement in screening techniques
    • 3.2.3 Rising awareness in the emerging market
  • 3.3 Market Restraint Analysis
    • 3.3.1 Limited implementation of public health screening
  • 3.4 Carrier screening - SWOT Analysis, By Factor (political & legal, economic, and technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Carrier Screening Market: Market Position Analysis, 2022
  • 3.7 COVID-19 Impact Analysis

Chapter 4 Carrier Screening Market: Type Estimates & Trend Analysis

  • 4.1 Carrier screening Market: Type Movement Analysis
  • 4.2 Expanded carrier screening
    • 4.2.1 Expanded carrier screening market
  • 4.3 Targeted disease carrier screening
    • 4.3.1 Targeted disease carrier screening market

Chapter 5 Carrier Screening Market: Medical Conditions Estimates & Trend Analysis

  • 5.1 Carrier Screening Market: Medical Conditions Movement Analysis
  • 5.2 Cystic fibrosis
    • 5.2.1 Cystic fibrosis market
  • 5.3 Tay-Sachs
    • 5.3.1 Tay-Sachs market
  • 5.4 Gaucher disease
    • 5.4.1 Gaucher disease market
  • 5.5 Sickle cell disease
    • 5.5.1 Sickle cell disease market
  • 5.6 Spinal muscular atrophy
    • 5.6.1 Spinal muscular atrophy market
  • 5.7 Other
    • 5.7.1 Other market

Chapter 6 Carrier screening Market: Technology Estimates & Trend Analysis

  • 6.1 Carrier screening Market: Technology Movement Analysis
  • 6.2 DNA sequencing
    • 6.2.1 DNA sequencing market
  • 6.3 Polymerase chain reaction
    • 6.3.1 Polymerase chain reaction market
  • 6.4 Microarrays
    • 6.4.1 Microarrays market
  • 6.5 Other
    • 6.5.1 Other market

Chapter 7 Carrier screening Market: End-user Estimates & Trend Analysis

  • 7.1 Carrier screening Market: End-user Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospitals market
  • 7.3 Laboratories
    • 7.3.1 Laboratories market
  • 7.4 Physician offices & clinics
    • 7.4.1 Physician offices & clinics market
  • 7.5 Other
    • 7.5.1 Other market

Chapter 8 Carrier screening Market: Regional Estimates & Trend Analysis, by Type, Medical Condition, Technology, End-user

  • 8.1 Carrier Screening Market Share By Region, 2022 & 2030
  • 8.2 North America
    • 8.2.1 SWOT Analysis
      • 8.2.1.1 North America carrier screening market, by type
      • 8.2.1.2 North America carrier screening market, by medical condition
      • 8.2.1.3 North America carrier screening market, by technology
      • 8.2.1.4 North America carrier screening market, by end-user
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 Target Disease Prevalence
      • 8.2.2.3 Competitive Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
      • 8.2.2.6 U.S. carrier screening market, by type
      • 8.2.2.7 U.S. carrier screening market, by medical condition
      • 8.2.2.8 U.S. carrier screening market, by technology
      • 8.2.2.9 U.S. carrier screening market, by end-user
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Target Disease Prevalence
      • 8.2.3.3 Competitive Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
      • 8.2.3.6 Canada carrier screening market, by type
      • 8.2.3.7 Canada carrier screening market, by medical condition
      • 8.2.3.8 Canada carrier screening market, by technology
      • 8.2.3.9 Canada carrier screening market, by end-user
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe carrier screening market, by type
      • 8.3.1.2 Europe carrier screening market, by medical condition
      • 8.3.1.3 Europe carrier screening market, by technology
      • 8.3.1.4 Europe carrier screening market, by end-user
    • 8.3.2 Germany
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Target Disease Prevalence
      • 8.3.2.3 Competitive Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
      • 8.3.2.6 Germany carrier screening market, by type
      • 8.3.2.7 Germany carrier screening market, by medical condition
      • 8.3.2.8 Germany carrier screening market, by technology
      • 8.3.2.9 Germany carrier screening market, by end-user
    • 8.3.3 U.K.
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Target Disease Prevalence
      • 8.3.3.3 Competitive Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
      • 8.3.3.6 U.K. carrier screening market, by type
      • 8.3.3.7 U.K. carrier screening market, by medical condition
      • 8.3.3.8 U.K. carrier screening market, by technology
      • 8.3.3.9 U.K. carrier screening market, by end-user
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 Target Disease Prevalence
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
      • 8.3.4.6 France carrier screening market, by type
      • 8.3.4.7 France carrier screening market, by medical condition
      • 8.3.4.8 France carrier screening market, by technology
      • 8.3.4.9 France carrier screening market, by end-user
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Target Disease Prevalence
      • 8.3.5.3 Competitive Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
      • 8.3.5.6 Italy carrier screening market, by type
      • 8.3.5.7 Italy carrier screening market, by medical condition
      • 8.3.5.8 Italy carrier screening market, by technology
      • 8.3.5.9 Italy carrier screening market, by end-user
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Target Disease Prevalence
      • 8.3.6.3 Competitive Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
      • 8.3.6.6 Spain carrier screening market, by type
      • 8.3.6.7 Spain carrier screening market, by medical condition
      • 8.3.6.8 Spain carrier screening market, by technology
      • 8.3.6.9 Spain carrier screening market, by end-user
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Target Disease Prevalence
      • 8.3.7.3 Competitive Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
      • 8.3.7.6 Denmark carrier screening market, by type
      • 8.3.7.7 Denmark carrier screening market, by medical condition
      • 8.3.7.8 Denmark carrier screening market, by technology
      • 8.3.7.9 Denmark carrier screening market, by end-user
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Target Disease Prevalence
      • 8.3.8.3 Competitive Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
      • 8.3.8.6 Sweden carrier screening market, by type
      • 8.3.8.7 Sweden carrier screening market, by medical condition
      • 8.3.8.8 Sweden carrier screening market, by technology
      • 8.3.8.9 Sweden carrier screening market, by end-user
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Target Disease Prevalence
      • 8.3.9.3 Competitive Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
      • 8.3.9.6 Norway carrier screening market, by type
      • 8.3.9.7 Norway carrier screening market, by medical condition
      • 8.3.9.8 Norway carrier screening market, by technology
      • 8.3.9.9 Norway carrier screening market, by end-user
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific carrier screening market, by type
      • 8.4.1.2 Asia Pacific carrier screening market, by medical condition
      • 8.4.1.3 Asia Pacific carrier screening market, by technology
      • 8.4.1.4 Asia Pacific carrier screening market, by end-user
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Target Disease Prevalence
      • 8.4.2.3 Competitive Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
      • 8.4.2.6 Japan carrier screening market, by type
      • 8.4.2.7 Japan carrier screening market, by medical condition
      • 8.4.2.8 Japan carrier screening market, by technology
      • 8.4.2.9 Japan carrier screening market, by end-user
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 Target Disease Prevalence
      • 8.4.3.3 Competitive Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
      • 8.4.3.6 China carrier screening market, by type
      • 8.4.3.7 China carrier screening market, by medical condition
      • 8.4.3.8 China carrier screening market, by technology
      • 8.4.3.9 China carrier screening market, by end-user
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 Target Disease Prevalence
      • 8.4.4.3 Competitive Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
      • 8.4.4.6 India carrier screening market, by type
      • 8.4.4.7 India carrier screening market, by medical condition
      • 8.4.4.8 India carrier screening market, by technology
      • 8.4.4.9 India carrier screening market, by end-user
    • 8.4.5 South Korea
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Target Disease Prevalence
      • 8.4.5.3 Competitive Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
      • 8.4.5.6 South Korea carrier screening market, by type
      • 8.4.5.7 South Korea carrier screening market, by medical condition
      • 8.4.5.8 South Korea carrier screening market, by technology
      • 8.4.5.9 South Korea carrier screening market, by end-user
    • 8.4.6 Australia
      • 8.3.9.1 Key Country Dynamics
      • 8.4.6.2 Target Disease Prevalence
      • 8.4.6.3 Competitive Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
      • 8.4.6.6 Australia carrier screening market, by type
      • 8.4.6.7 Australia carrier screening market, by medical condition
      • 8.4.6.8 Australia carrier screening market, by technology
      • 8.4.6.9 Australia carrier screening market, by end-user
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Target Disease Prevalence
      • 8.4.7.3 Competitive Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
      • 8.4.7.6 Thailand carrier screening market, by type
      • 8.4.7.7 Thailand carrier screening market, by medical condition
      • 8.4.7.8 Thailand carrier screening market, by technology
      • 8.4.7.9 Thailand carrier screening market, by end-user
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America carrier screening market, by type
      • 8.5.1.2 Latin America carrier screening market, by medical condition
      • 8.5.1.3 Latin America carrier screening market, by technology
      • 8.5.1.4 Latin America carrier screening market, by end-user
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Target Disease Prevalence
      • 8.5.2.3 Competitive Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
      • 8.5.2.6 Brazil carrier screening market, by type
      • 8.5.2.7 Brazil carrier screening market, by medical condition
      • 8.5.2.8 Brazil carrier screening market, by technology
      • 8.5.2.9 Brazil carrier screening market, by end-user
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Target Disease Prevalence
      • 8.5.3.3 Competitive Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
      • 8.5.3.6 Mexico carrier screening market, by type
      • 8.5.3.7 Mexico carrier screening market, by medical condition
      • 8.5.3.8 Mexico carrier screening market, by technology
      • 8.5.3.9 Mexico carrier screening market, by end-user
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Target Disease Prevalence
      • 8.5.4.3 Competitive Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Reimbursement Scenario
      • 8.5.4.6 Argentina carrier screening market, by type
      • 8.5.4.7 Argentina carrier screening market, by medical condition
      • 8.5.4.8 Argentina carrier screening market, by technology
      • 8.5.4.9 Argentina carrier screening market, by end-user
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA carrier screening market, by type
      • 8.6.1.2 MEA carrier screening market, by medical condition
      • 8.6.1.3 MEA carrier screening market, by technology
      • 8.6.1.4 MEA carrier screening market, by end-user
    • 8.6.2 South Africa
      • 8.6.4.1 Key Country Dynamics
      • 8.6.2.2 Target Disease Prevalence
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
      • 8.6.2.6 Argentina carrier screening market, by type
      • 8.6.2.7 Argentina carrier screening market, by medical condition
      • 8.6.2.8 Argentina carrier screening market, by technology
      • 8.6.2.9 Argentina carrier screening market, by end-user
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Target Disease Prevalence
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
      • 8.6.3.6 Saudi Arabia carrier screening market, by type
      • 8.6.3.7 Saudi Arabia carrier screening market, by medical condition
      • 8.6.3.8 Saudi Arabia carrier screening market, by technology
      • 8.6.3.9 Saudi Arabia carrier screening market, by end-user
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Target Disease Prevalence
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
      • 8.6.4.6 UAE carrier screening market, by type
      • 8.6.4.7 UAE carrier screening market, by medical condition
      • 8.6.4.8 UAE carrier screening market, by technology
      • 8.6.4.9 UAE carrier screening market, by end-user
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Target Disease Prevalence
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
      • 8.6.5.6 Kuwait carrier screening market, by type
      • 8.6.5.7 Kuwait carrier screening market, by medical condition
      • 8.6.5.8 Kuwait carrier screening market, by technology
      • 8.6.5.9 Kuwait carrier screening market, by end-user

Chapter 9 Competitive Landscape

  • 9.1 Participant's overview
  • 9.2 Financial performance
  • 9.3 Participant categorization
    • 9.3.1 Market leaders
      • 9.3.1.1 Carrier screening market share analysis, 2022
      • 9.3.1.2 Company profiles
      • 9.3.1.2.1 Thermo Fisher Scientific Inc.
      • 9.3.1.2.2 Myriad Genetics, Inc.
      • 9.3.1.2.3 Cepheid
      • 9.3.1.2.4 Laboratory Corporation of America Holdings
      • 9.3.1.2.5 Otogenetics
      • 9.3.1.2.6 Illumina Inc.
      • 9.3.1.2.7 MedGenome
      • 9.3.1.2.8 GeneTech
      • 9.3.1.2.9 Centogene N.V.
      • 9.3.1.2.10 F. Hoffman-La Roche Limited
    • 9.3.2 Strategy mapping
      • 9.3.2.1 Expansion
      • 9.3.2.2 Acquisition
      • 9.3.2.3 Collaborations
      • 9.3.2.4 Product/service launch
      • 9.3.2.5 Partnerships
      • 9.3.2.6 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 5 Global Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 7 Global Carrier screening Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 11 North America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 13 U.S. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 15 U.S. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 17 Canada Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 19 Canada Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 24 Europe Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Europe Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 26 Germany Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 28 Germany Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 Germany Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 30 U.K. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 U.K. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 32 U.K. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 34 France Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 France Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 36 France Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 38 Italy Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 40 Italy Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 42 Spain Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 44 Spain Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 46 Denmark Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 48 Denmark Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 50 Sweden Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 52 Sweden Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 54 Norway Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 56 Norway Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 63 China Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 China Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 65 China Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 China Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 67 Japan Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 69 Japan Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Japan Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 71 India Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 India Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 73 India Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 India Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 75 South Korea Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 77 South Korea Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 South Korea Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 79 Australia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 81 Australia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Australia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 83 Thailand Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 85 Thailand Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 Thailand Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 87 Latin America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 90 Latin America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Latin America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 92 Brazil Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 94 Brazil Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Brazil Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 96 Mexico Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 98 Mexico Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Mexico Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 100 Argentina Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 102 Argentina Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Carrier screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 109 South Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 111 South Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 117 UAE Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 119 UAE Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 UAE Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Carrier screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Carrier screening Market, by End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Carrier screening Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Carrier screening Market: Type Movement Analysis
  • Fig. 17 Global Carrier screening Market, for Expanded Carrier Screening, 2018 - 2030 (USD Million)
  • Fig. 18 Global Carrier screening Market, for Targeted Disease, 2018 - 2030 (USD Million)
  • Fig. 19 Global Carrier screening Market: Medical Condition Movement Analysis
  • Fig. 20 Global Carrier screening Market, for Cystic Fibrosis, 2018 - 2030 (USD Million)
  • Fig. 21 Global Carrier screening Market, for Tay-Sachs, 2018 - 2030 (USD Million)
  • Fig. 22 Global Carrier screening Market, for Gaucher Disease, 2018 - 2030 (USD Million)
  • Fig. 23 Global Carrier screening Market, for Sickle Cell Disease, 2018 - 2030 (USD Million)
  • Fig. 24 Global Carrier screening Market, for Spinal Muscular Atrophy, 2018 - 2030 (USD Million)
  • Fig. 25 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 26 Global Carrier screening Market: Technology Movement Analysis
  • Fig. 27 Global Carrier screening Market, for DNA Sequencing, 2018 - 2030 (USD Million)
  • Fig. 28 Global Carrier screening Market, for Polymerase Chain Reaction, 2018 - 2030 (USD Million)
  • Fig. 29 Global Carrier screening Market, for Microarrays, 2018 - 2030 (USD Million)
  • Fig. 30 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 31 Global Carrier screening Market: End User Movement Analysis
  • Fig. 32 Global Carrier screening Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 33 Global Carrier screening Market, for Laboratories, 2018 - 2030 (USD Million)
  • Fig. 34 Global Carrier screening Market, for Physician Offices & Clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Outlook, 2022 & 2030
  • Fig. 38 Global Carrier screening Market: Region Movement Analysis
  • Fig. 39 North America Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 45 France Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 53 China Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 54 India Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Carrier screening Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Carrier screening Market, 2018 - 2030 (USD Million)